Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pharmaxis Ltd ( (AU:SNT) ) just unveiled an announcement.
Pharmaxis Ltd has released a shareholder update for the March quarter, focusing on its subsidiary, Syntara. The update includes forward-looking statements about Syntara’s future financial position and the potential of its products. However, it cautions that actual results may differ due to various risks and uncertainties, and there is no guarantee of success in developing or partnering products in their pipeline.
More about Pharmaxis Ltd
YTD Price Performance: -38.75%
Average Trading Volume: 3,589,326
Technical Sentiment Signal: Buy
Current Market Cap: A$79.58M
Find detailed analytics on SNT stock on TipRanks’ Stock Analysis page.